RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus.

J Antibiot (Tokyo)

Antibiotics Laboratory, Discovery Research Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Published: November 2006

We found that the strain Aspergillus fumigatus var. fumigatus RK95-113 produced a new angiogenesis inhibitor, RK-95113. Spectroscopic analyses identified the structure of RK-95113 as a new fumagillin-related small molecule. RK-95113 preferentially inhibited the growth of human umbilical vein endothelial cells (HUVECs) rather than that of human normal fibroblasts in cell proliferation assays and blocked endothlial cell migration induced by vascular endothelial growth factor (VEGF).

Download full-text PDF

Source
http://dx.doi.org/10.1038/ja.2006.97DOI Listing

Publication Analysis

Top Keywords

angiogenesis inhibitor
8
aspergillus fumigatus
8
rk-95113
4
rk-95113 angiogenesis
4
inhibitor produced
4
produced aspergillus
4
fumigatus strain
4
strain aspergillus
4
fumigatus var
4
var fumigatus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!